# Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

> **NCT00174460** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 33 (actual)

## Conditions studied

- Growth Hormone Therapy
- Infant, Very Low Birth Weight

## Interventions

- **DRUG:** Somatropin
- **OTHER:** Control Arm

## Key facts

- **NCT ID:** NCT00174460
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-03
- **Final completion:** 2010-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174460, "Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00174460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*